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Fundamental questions to sun protection: A continuous
education symposium at the University of Zürich on "Vitamin D,
immune system and sun protection"
Abstract
Since exposure to sunlight is a main factor in the development of non-melanoma skin cancer and there
are associations between malignant melanoma and short-term intense ultraviolet (UV) exposure,
particularly burning in childhood, strict protection from UV-radiation is recommended. However, up to
90% of all requisite vitamin-D has to be formed within the skin through the action of the sun - a serious
problem, for a connection between vitamin-D deficiency, demonstrated in epidemiological studies, and
various types of cancer and other diseases has been confirmed. A UVB-triggered skin autonomous
vitamin D3 synthesis pathway has recently been described, producing the active Vitamin D metabolite
calcitriol. This cutaneous vitamin D3 pathway is unique. Keratinocytes and dendritic cells can convert
vitamin D to calcitriol. Cutaneous T cells activated in the presence of calcitriol express the chemokine
receptor CCR10 attracting them to the chemokine CCL27 that keratinocytes express selectively in the
epidermis, and migrate from dermal layers of the skin to the epidermis under UV radiation. Thus,
calcitriol has endocrine roles beyond its calciotropic action, including cell growth and cancer
prevention. Therefore, strict sun protection procedures to prevent skin cancer may induce the risk of
vitamin-D deficiency. As there is evidence that the protective effect of less intense solar radiation can
outweigh its mutagenic effect, better balanced approaches to sun protection should be sought.
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UV Filters and Endocrine Disruptors
Endocrine disruptors (EDC) (hormonally active agents) are exog-
enous substances or mixtures that alter functions of the endocrine 
system and consequently cause adverse health effects in an intact 
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organism or its progeny (International Programme on Chemical 
Safety, IPCS). A recent scientific statement by the American 
Endocrine Society1 describes EDC’s as a possible health threat: 
Present in our environment, food and consumer products, 
EDC’s are competent to affect male and female reproduction, 
brain development and functions, breast development and can-
cer, prostate cancer, thyroid, metabolism (metabolic syndrome) 
and cardiovascular system. Convergent results from animal mod-
els, from human clinical observations and epidemiological stud-
ies identify EDC’s as a significant concern to public health.
EDC actions are most deleterious during early developmental 
periods by disrupting hormone enforced organizational events. 
Most vulnerable life stages to EDC therefore are the prenatal 
and early postnatal periods when organ systems are most sensi-
tive. Permanent effects might occur later in life. EDC’s may act 
at concentrations far below threshold of conventional toxicity. 
In conventional toxicity tests these chemicals remained largely 
unnoticed, because of complex dose-response curves that involve 
cellular mechanism originating from multiple signalling path-
ways. EDC effects may not only impact the exposed individual 
but may be transmitted to subsequent generations via epigenetic 
modifications.2
The range of molecules exhibiting EDC—characteristics is 
broad comprising organochloride pesticides, industrial chemi-
cal, plastics and plasticizers, cosmetic ingredients and many more 
chemicals in widespread use. We identified some of the ultraviolet 
UV filters used in sun protection (sunscreens) and in diverse cos-
metic products as endocrinologically active.3 Two of these sub-
stances were identified as reprotoxicants delaying male puberty, 
causing changes in reproductive organ weights, estrous cycle, 
female sexual behavior and of estrogen target genes in brain and 
reproductive organs.4
How Much of Sun Screens do We Really Need?
Assessment of chemical risk requires information on quality 
and quantity of chemical impact. In a monitoring study on 
Since exposure to sunlight is a main factor in the development 
of non-melanoma skin cancer and there are associations 
between malignant melanoma and short-term intense 
ultraviolet (Uv) exposure, particularly burning in childhood, 
strict protection from Uv-radiation is recommended. However, 
up to 90% of all requisite vitamin D has to be formed within 
the skin through the action of the sun—a serious problem, for 
a connection between vitamin D deficiency, demonstrated 
in epidemiological studies, and various types of cancer and 
other diseases has been confirmed. A UvB-triggered skin 
autonomous vitamin D3 synthesis pathway has recently been 
described, producing the active vitamin D metabolite calcitriol. 
This cutaneous vitamin D3 pathway is unique. Keratinocytes and 
dendritic cells can convert vitamin D to calcitriol. Cutaneous 
T cells activated in the presence of calcitriol express the 
chemokine receptor CCr10 attracting them to the chemokine 
CCL27 that keratinocytes express selectively in the epidermis, 
and migrate from dermal layers of the skin to the epidermis 
under Uv radiation. Thus, calcitriol has endocrine roles beyond 
its calciotropic action, including cell growth and cancer 
prevention. Therefore, strict sun protection procedures to 
prevent skin cancer may induce the risk of vitamin D deficiency. 
As there is evidence that the protective effect of less intense 
solar radiation can outweigh its mutagenic effect, better 
balanced approaches to sun protection should be sought.
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inhibit the growth of human cancers is not new (reviewed in ref. 
10). Based on an apparent deficit of non-skin cancer among US 
Navy personnel, who experienced an excess of skin cancer, Peller 
concluded in 1936 that skin cancers induce a relative immunity 
to other types of cancer. In consequence, he advocated the delib-
erate induction of skin cancers, which were easily to detect and 
to treat, as a form of vaccination against more life-threatening 
and less treatable cancers. Over the 20th century the field of vita-
min D and cancer has changed considerably. By now a negative 
association has been confirmed6 between increased risk of dying 
of various internal malignancies (e.g., breast, colon, prostate 
and ovarian cancer) and decreasing latitude towards the equa-
tor (increased sunlight levels). Additionally, a correlation of this 
latitudinal association with decreased vitamin D serum levels was 
demonstrated.7 Black men, who have an increased risk to develop 
vitamin D deficiency, have also an increased risk of prostate can-
cer and develop a more aggressive form of the disease. In conclu-
sion, the evolution of our understanding of the role of vitamin D 
in cancer parallels our understanding of the importance of vita-
min D for rickets. In both diseases, epidemiologic observations 
about consequences of sun exposure preceeded experimental 
observations and were subsequently validated by them. Apperly’s 
insightful observations on sunlight exposure and cancer, like 
those of Theobold Palm on the protective effects of UV-radiation 
on rickets half a century earlier, passed virtually unnoticed by 
his contemporaries, only to be re-discovered by epidemiologists 
decades later.
Specifics of the Cutaneous Vitamin D3 Pathway
Bodo Lehman describes a skin autonomous vitamin D
3 
synthesis pathway. Vitamin D
3
, also known as cholecalciferol 
or calciol, is produced from cutaneous 7-dehydrocholesterol 
(7-DHC, provitamin D
3
) by an UVB-triggered photochemical 
reaction.11 The production of vitamin D3 in the skin strongly 
depends on the wavelength, the dose of the UVB and most 
probably the ratio of UVB (wavelength range: 280–320 nm) to 
UVA (wavelength range: 320–380 nm) in the solar spectrum.12 
The efficacy of UVB radiation on the vitamin D
3
 synthesis dra-
matically decreases by 80% within a very small wavelength range 
from 300 nm to 310 nm. A very low conversion rate of only 0.6% 
has been found at 320 nm.12 These different conversion rates are 
most probably attributed to the fact that four photo-reversible 
reactions and one non-reversible phototransformation with over-
all nine different action spectra are involved in the synthesis of 
previtamin D
3
, which is the direct precursor of vitamin D
3
. The 
epidermal milieu including lipid layers, multibilayers, skin pig-
ment and the concentration of 7-DHC is most probably respon-
sible for selectivity, efficiency but also interindividual variations 
of the previtamin D
3
 photosynthesis in human skin. Vitamin D
3
 
should be better described as an biologically inert prohormone 
which is then activated to the hormone 1α, 25-dihydroxyvitamin 
D
3
 (calcitriol) by two subsequent hydroxylations in the liver and 
kidney.13-15 It is interesting that enzymatic formation of calcitriol 
also occurs in many non-renal tissues including prostate, breast, 
intestine, lung and other tissues.16-18 Calcitriol contributes not 
human breast milk we found 6 out of 8 analyzed UV filters in 
mother/child cohorts from 3 different years. Use of sunscreens 
or other cosmetic products containing these UV filters was sig-
nificantly correlated with their presence in human milk. UV 
filters as cosmetic ingredients in make ups, body lotions, face 
creams, lip sticks or bubble baths were found to be a relevant 
source of exposure.4 The link between product use and inter-
nal exposure distinguishes UV filters from other EDC’s pres-
ent in human milk such as PCB’s, organochlor pesticides and 
phthalates, other environmental chemicals, where exposure is 
more general. This makes it possible to reduce exposure dur-
ing critical vulnerable periods such as pregnancy and nursing. 
This might protect the infant from additional and unnecessary 
chemical burden in breast milk. In this context, it becomes 
important to discuss the optimal amount and method of pro-
tection against UV light.
Sun protection and sun exposure should be carefully balanced 
as UV radiation is a pre-requisite to produce sufficient vitamin 
D in our skin and body. How much of sun screens do we really 
need?
Sun Exposure and Skin Cancer
According to Jörg Reichrath there is no doubt that exposure to 
sunlight is the main reason for the development of non-melanoma 
skin cancer. In addition, various reports analysing sun expo-
sure parameters have consistently demonstrated an association 
between the development of malignant melanoma and short-
term intense UV-radiation exposure, particularly burning in 
childhood.5
In consequence, strict protection recommendations from solar 
and artificial UV-radiation represent a fundamental part of pre-
vention programmes aimed at reducing UV-radiation-induced 
skin damage and skin cancer. Today, sun protection recommen-
dations include use of broad spectrum protection sunscreens, 
protective clothing and avoidance of sunlight. Most sunscreen 
products combine chemical UV-radiation-absorbing sunscreens 
and physical anorganic sunscreens, which reflect UV-radiation, 
to provide broad spectrum protection.
One has to keep in mind that up to 90% of all requisite vita-
min D has to be formed within the skin through the action of 
the sun—a serious problem, for a connection between vitamin 
D deficiency and various types of cancer (e.g., colon-, prostate- 
and breast cancer) and other diseases (including bone diseases, 
cardio-vascular diseases, infectious diseases) has now been con-
firmed in a large number of studies.6-10
An Open Debate among Dermatologists
As a consequence, this association between vitamin D deficiency 
and various diseases including internal malignancies has now 
opened a debate among dermatologists, whether UV-radiation 
protection recommendations to prevent skin cancer should be 
moderated. What is the rationale that vitamin D deficiency may 
be associated with an increased risk of various diseases including 
certain types of cancer? The idea that sunlight and vitamin D 
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radiation on human skin are partly and indirectly mediated by 
biologically active vitamin D
3
 metabolites.
Vitamin D, Dendritic Cells and T Cells in Skin
T-cell mediated skin diseases and skin problems affect millions 
of people every day. Resulting skin lesions can be difficult to 
treat and it is important to develop local and more targeted 
treatments. Recent data on the function of microenvironmental 
factors may help develop such therapies. T cells and their recir-
culation are important for immune surveillance and in response 
to infections. The infiltration of T cells into lymphoid tissues 
and inflammatory sites is a multistep process that is tightly 
regulated by the expression of adhesion molecules, chemokine 
receptors and the interaction between the T cells and vascular 
endothelium.33 To target T cells to different tissues, the immune 
system takes cues from various sources, including vitamins from 
food and sunlight. Dendritic cells (DCs) are important in this 
process. They use signals in their local environment to induce 
the expression of tissue-specific molecules on the T cells. It is 
known that DCs in lymph nodes draining the skin preferen-
tially induce the expression of skin-homing receptors on T cells, 
while dendritic cells in lymph nodes draining the gut induce the 
expression of gut-homing receptors.34 Although receptors and 
molecules involved in lymphocyte trafficking have been studied 
extensively, it is not clear what induces or regulates the expres-
sion of these tissue-specific molecules. How is this specificity 
determined? Vitamins A and D and their metabolites are known 
to affect both innate and adaptive immune responses, and have 
been shown to suppress inflammation and lymphocyte function, 
and they can induce the generation of regulatory cells in the 
skin. Recently, they have also been shown to affect the expres-
sion of receptors involved in trafficking of T cells into the gut 
and the skin.
Vitamin A can be metabolized by DCs and has been shown 
to induce the expression of gut-specific receptors on T cells and 
promote their migration to the gut.35 A similar mechanism 
also applies for skin-associated vitamins, namely vitamin D. 
During UVB exposure from the sun, a signal can be generated 
through local formation of vitamin D
3
, which imprints T cells 
with skin-specific receptors. Vitamin D
3
 is relatively inactive 
and is mainly metabolized in the liver and kidneys. However, 
DCs have the enzymes needed to convert inactive vitamin D to 
its most active metabolite, 1,25(OH)
2
D3.36 When T cells were 
activated in the presence of 1,25(OH)
2
D3, the expression of the 
chemokine receptor CCR10 was induced on the T cells. This 
receptor attracts T cells to the chemokine CCL27, which is selec-
tively expressed by keratinocytes of the epidermis (Fig. 1) and 
mobilizes the T cells within the skin by promoting migration 
from dermal layers of the skin to the epidermis.37 At the same 
time, the expression of gut-specific receptors was decreased on 
the T cells.36 Thus, UVB-induced increase of skin-mobilizing 
T cells could be a way of enhancing T-cell immune responses in 
the skin when needed. These could be both effector T cells as 
well as regulatory T cells.38 The effective concentrations of vita-
min D
3
 for inducing skin specificity on T cells can be found in 
only to the maintenance of the calcium and phosphate homeo-
stasis but also acts as a regulator of various biological processes 
including cell growth, differentiation, apoptosis, cancer preven-
tion, immunological processes, defense, photoprotection and of 
other cell functions.19-21 Genomic effects of calcitriol are medi-
ated by the vitamin D receptor (VDR). By contrast, rapid non-
genomic effects are mediated by a putative membrane associated 
vitamin D receptor (mVDR).
Previously, Bodo Lehmann’s group demonstrated that UVB 
irradiation of cultured neonatal keratinocytes supplemented 
with 7-DHC at about 300 nm22-25 and of human skin in vivo25 
activates the metabolism of 7-dehydrocholesterol to hormonally 
active calcitriol. The enzymatic conversion of vitamin D
3
 to cal-
citriol in keratinocytes is mainly catalyzed by the mixed func-
tion oxidases CYP27A1 and CYP27B1.12-14 The synthesis rate of 
calcitriol is positively correlated to the substrate concentration 
of vitamin D
3
.22 In addition, the activity of both anabolic and 
catabolic vitamin D hydroxylases determines the concentration 
of calcitriol in keratinocytes.26 Calcitriol regulates a number 
of genes in keratinocytes, and can act in an autocrine and/or 
paracrine manner.27
Recently, it has been demonstrated that epidermal kerati-
nocytes and dermal fibroblasts are metabolically different with 
regard to the hydroxylation of vitamin D
3
.28 Calcitriol is derived 
from keratinocytes which have the complete enzyme machinery 
to produce and degrade this metabolite. By contrast, fibroblasts 
can only produce the direct precursor of calcitriol, 25-hydroxyvi-
tamin D
3
 (calcidiol, 25OHD3). Calcidiol from fibroblasts can 
diffuse to basal keratinocytes and to the blood circulation. This 
dermal—epidermal substrate transfer of calcidiol may result in 
higher synthesis rate of calcitriol in keratinocytes compared to 
epidermal keratinocytes alone.28
This cutaneous vitamin D
3
 pathway is unique, but its rele-
vance for healthy and diseased skin is widely unknown as of yet. 
On the other hand, it is well known that both calcitriol and UVB 
radiation exert potent antipsoriatic and other beneficial effects in 
human skin.29 We hypothesize from our findings that the antip-
soriatic effect of UVB radiation is attributed at least in part to 
UVB-triggered cutaneous synthesis of calcitriol.
It is worth mentioning that photosynthesized vitamin D
3
 can 
also be sequentially hydroxylated by the CYP11A1 to 20,22-dihy-
droxyvitamin D
3
 and other unknown trihydroxylated vitamin 
D
3
 metabolites in cultured keratinocytes.30 The pathophysiologi-
cal role of this pathway is unknown yet.
It has been known for a long time that formation of singlet 
oxygen is induced by UVA radiation within the skin, and this 
reactive oxygen species is seemingly involved in cell damaging and 
tumor promoting action of UVA on skin.31 Of note, vitamin D
3
 is 
photo-oxidized by singlet oxygen to 6R- and 6S-epidioxy-vitamin 
D
3
 in vitro. In particular the 6R-epidioxy-vitamin D
3 
develops sig-
nificant biological activity in rats.32 The physiological role of these 
endoperoxides for humans remains to be ascertained.
Physiological and pathophysiological roles of vitamin D
3
 
metabolites produced by enzymatic and photochemical reactions 
in the skin are widely unknown and need to be clarified. It can 
be postulated from these findings that biological effects of UV 
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skin tumors including melanoma.41 In contrast to the internal 
cancers discussed above, many studies have shown that the 
incidence of malignant melanoma increases with decreasing 
latitude towards the equator.42 However, in contrast to short-
term intense exposure, more chronic less intense exposure 
has not been found to be a risk factor for the development 
of malignant melanoma and in fact has been found in some 
studies to be protective.41-43 It may be speculated whether 
these connections may be an explanation for the finding of an 
increased risk to develop melanoma after sunscreen use, that 
was reported recently.44
How Much Vitamin D do We Need  
to Achieve a Protecting Effect Against Cancer  
and Other Diseases?
The US Recommended Dietary Allowance (RDA) of vitamin D 
from 1989 is 200 IU.45 Yet, studies have shown that 200 IU/day 
has no effect on bone status.42 It has been recommended that 
adults may need, at a minimum, five times the RDA, or 1,000 
IU, to adequately prevent bone fractures, protect against some 
cancers and derive other broad-ranging health benefits.45 In 
conclusion, the 1989 RDA of 200 IU is antiquated, and the 
newer 600 IU Daily Reference Intake (DRI) dose for adults 
older than 70 is still not adequate.45 It has been suggested that 
even the 2,000 IU upper tolerable intake, the official safety 
limit, does not deliver the amounts of vitamin D that may be 
optimal.45 On a sunny summer day, total body sun exposure 
produces approximately 10,000 IU vitamin D per day. As a 
result, concerns about toxic overdose with dietary supplements 
that exceed 800 IU are poorly founded. It has been speculated 
that a person would have to consume almost 67 times more 
vitamin D than the current 600 IU recommended intake for 
older adults to experience symptoms of overdosage.45 Vieth 
believes people need 4,000–10,000 IU vitamin D daily and 
that toxic side effects are not a concern until a 40,000 IU/day 
dose.45 Other researchers agree with these findings. They sug-
gest that older adults, sick adults, and “perhaps all adults” need 
800–1,000 IU daily. They indicate that daily doses of 2,400 
IU—four times the recommended intake—can be consumed 
safely.43
What conclusions do we draw from these findings, most 
importantly the demonstration of an association between vita-
min D deficiency and the occurrence of various types of cancer? 
The most important take home message, especially for derma-
tologists, is that strict sun protection procedures to prevent skin 
cancer may induce the severe health risk of vitamin D deficiency. 
There is no doubt that UV radiation is mutagenic and is the 
main reason for the development of non-melanoma skin cancer. 
Therefore, excessive sun exposure has to be avoided, particu-
larly burning in childhood. To reach this goal, the use of sun-
screens as well as the wearing of protective clothes and glasses is 
absolutely important. Additionally, sun exposure around mid-
day should be avoided during the summer in most latitudes. 
However, the dermatological community has to recognize that 
there is evidence that the protective effect of less intense solar 
skin, thus, this mechanism may be occurring locally in the skin. 
In contrast, the dietary form of vitamin D was not as effective 
as the sunlight-induced form at inducing CCR10 expression.36 
Other factors that are present in the skin may also have effects 
on trafficking receptors associated with migration in the skin. 
They may be acting locally in skin, and/or possibly taken up by 
dendritic cells that transfer them to the draining lymph nodes, 
where they are present during T-cell activation. Several such fac-
tors are under investigation. Combinatorial treatment where the 
presence or absence of such factors is manipulated may prove 
to be a beneficial therapeutic approach to develop targeted local 
treatments of skin diseases.
1,25(OH)2D is not Exclusively Considered  
as a Calciotropic Hormone
In contrast to earlier assumptions, not only skin, but pros-
tate, colon, breast, and many other tissues express the enzyme 
to convert 25(OH)D to its active form, 1,25(OH)
2
D.39-41 
Therefore 1,25(OH)
2
D is now not exclusively considered as 
a calciotropic hormone but also as a locally produced potent 
hormone regulating various cellular functions including cell 
growth.10,40 In consequence, a whole number of recently pub-
lished studies point at a protective effect of locally produced 
vitamin D in the pathogenesis of various malignancies.10,41 
Interestingly, new findings demonstrate a contribution of 
the skin vitamin D system to the pathogenesis of malignant 
Figure 1. UvB rays from sunlight generates vitamin D3 from its precur-
sor in the skin. vitamin D3 is not very active and can be converted 
to both 25(OH)D3 and 1,25(OH)2D3 by dendritic cells. Dendritic cells 
come in close contact with T cells, and in the presence of vitamin D3, 
the CCr10 receptor is induced on the T cells. This attracts the T cells to 
CCL27, which is selectively produced and secreted by keratinocytes in 
the epidermis. Thus, once T cells have infiltrated the dermal layers of the 
skin from the cutaneous blood vessel, they can be mobilized within the 
skin and migrate to the epidermis. This way, T cells could be drawn to 
the epidermis when they are needed.
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Intentional UV Exposition Does Not Correct  
a Vitamin D Deficiency
Laurence Feldmeyer agrees with the idea that the recommended 
daily vitamin D intake of 800 IU cannot be obtained through diet 
only and requires oral supplementation.50 Although ultraviolet 
phototherapy has been shown to increase serum 25-hydroxyvita-
min D concentrations in several studies, usually no detailed dose 
or treatment frequency required for a particular response, or the 
quantitative effect of basic skin pigmentation were mentioned 
in the respective publications.45,51 Moreover, most of the stud-
ies were based on very small collectives and were of short dura-
tion. In a case series of 24 postmenopausal women with active 
plaque psoriasis treatment for 8–12 weeks, UVB broadband 
(UVBbb) increased serum levels of 25(OH)D3 1.62-folds from 
basal level.52 Almost all studies were performed with UVBbb. 
Recently, two studies investigated the influence of UVB nar-
rowband (UVBnb) on vitamin D in serum.53,54 They showed 
that low-dose UVBnb treatment induces a significant increase of 
the vitamin D status in persons with low initial levels of 25(OH)
D353, and that UVBnb is less efficient for the production of vita-
min D than UVBbb, as expected from the UV spectrum.54
Only two studies investigated the vitamin D plasma increase 
under psoralen-UVA (PUVA) therapy.55,56 Although the action 
spectrum for the conversion of 7-dehydrocholesterol to vita-
min D
3
 is thought to be within the UVB range (280–310 nm), 
the results of Rogers et al. suggest that the higher wavelengths 
of UVA (310–400 nm) may have an effect, too, at least in the 
presence of psoralen. Nevertheless, the possibility that the small 
amounts of UVB emitted by the lamps used may explain the 
increase either alone or in combination with UVA or psoralen, 
or both has not been ruled out. The stimulation of vitamin D 
synthesis by PUVA was short-lived. It had returned almost to 
pre-treatment levels by the third irradiation. Another study 
showed no effect of PUVA on serum vitamin D.56 Krause et al. 
measured blood pressure in nine patients under UVBbb and 
nine patients under UVA during 6 weeks, vitamin D in the 
UVA group remain unchanged.57 We could not find any studies 
on the effect of UVA1 (340–400 nm) on serum vitamin D in 
the medical literature. Contrary to UVA, UVA1 has almost no 
overlap with the UVB spectrum.
Feldmeyer et al. investigated the serum elevation of 25(OH)
D (the major circulating metabolite, used to determine vita-
min D status in a patient) under UVBnb and UVA1 therapy 
in patients undergoing phototherapy for a skin disease, in order 
to determine the effect of these nowadays frequently used wave-
lengths for phototherapy on vitamin D plasma levels, and par-
ticularly to test the dogma, that UVA has no effect on serum 
vitamin D. 25(OH)D was determined before the start of light 
therapy, as well as 1 week after the start of therapy and after 
completion of light therapy at 12 weeks.
The first preliminary results show that, as expected, serum 
vitamin D increases under UVBnb therapy. Under UVA/UVB 
we also have an increase in vitamin D, however, less clear than 
with UVBnb. Under UVA therapy, no increase in vitamin D 
was measured.
radiation outweighs its mutagenic effect. In consequence, many 
lives could be prolonged through careful exposure to sunlight 
or more safely, vitamin D supplementation, especially in non-
summer months. Therefore, recommendations of dermatolo-
gists on sun protection should be moderated.
As Michael Holick reported previously,46 we have learned 
that at most latitudes such as Boston, MA very short and lim-
ited solar exposure is sufficient to achieve “adequate” vitamin D 
levels. Exposure of the body in a bathing suit to one minimal 
erythemal dose (MED) of sunlight is equivalent to ingesting 
about 10,000 IU of vitamin D and it has been reported that 
exposure of less than 18% of the body surface (hands, arms and 
face) two to three times a week to a third to between a third and 
a half of an MED; (about 5 min for skin-type-2 adult in Boston 
at noon in July) in the spring, summer and autumn is more 
than adequate.46 Anyone intending to stay exposed to sunlight 
longer than recommended above should apply a sunscreen with 
a sufficient sun-protection factor to prevent sunburn and the 
damaging effects of excessive exposure to sunlight. Although 
further work is necessary to define the influence of vitamin D 
deficiency on the occurrence of melanoma and non-melanoma 
skin cancer, it is at present mandatory that especially dermatol-
ogists strengthen the importance of an adequate vitamin D sta-
tus if sun exposure is seriously curtailed. It has to be emphasized 
that in groups that are at high risk of developing vitamin D 
deficiency (e.g., nursing-home residents; patients with skin type 
I or patients under immunosuppressive therapy that must be 
protected from sun exposure), vitamin D status should be mon-
itored subsequently. Vitamin D deficiency should be treated, 
e.g., by giving vitamin D orally as recommended previously.46 It 
has been shown that a single dose of 50,000 IU vitamin D once 
a week for 8 weeks is efficient and safe to treat vitamin D defi-
ciency.47 In a meta analysis of randomized controlled trials sup-
plemental vitamin D in a dose of 700–1,000 IU prevented the 
risk of falling in older individuals by 19%.49 Another means of 
guaranteeing vitamin D sufficiency, especially in nursing-home 
residents, is to give 50,000 IU of vitamin D once a month. An 
alternative to prevent vitamin D deficiency would be the use of 
vitamin D containing ointments. However, it should be noted 
that vitamin D containing ointments are, at least in Europe, not 
allowed as cosmetics. These antiquated laws are the result of the 
fear of vitamin D intoxication that was evident in Europe in 
the 1950s48 and should be re-evaluated, for they do not reflect 
our present scientific knowledge. If we follow the guidelines 
discussed above carefully, they will ensure an adequate vitamin 
D status, thereby protecting us against adverse effects of strict 
sun protection recommendations. Most importantly, these 
measures will protect us sufficiently against the influence of 
vitamin D deficiency on the occurrence of various malignancies 
without increasing our risk to develop UV-induced skin cancer. 
To reach this goal it is of high importance that this information 
is transferred to every clinician, especially to dermatologists. 
Otherwise dermatologists will not be prepared for the mod-
eration of sun protection recommendations, that is necessary 
to protect us against vitamin D deficiency, cancer and other 
diseases.
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causality of vitamin D and cancer overall and skin cancer in 
particular.58 While more data is collected, Feldmeyer et al. 
f irmly believe that dermatological recommendations for sun 
protection by behaviour, clothing and sunscreen application 
should not be reconsidered at this point in time. This posi-
tion does not agree with the view of the other symposium 
speakers.
In conclusion, as UVA exposure does not increase vitamin 
D synthesis, and the UVBnb-induced increase in vitamin D 
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3
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cussed above, there is a controversy about the correlation and 
34. Mora JR, Iwata M, von Andrian UH. Vitamin effects 
on the immune system: vitamins A and D take centre 
stage. Nat Rev Immunol 2008; 8:685-98.
35. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato 
C, Song SY. Retinoic Acid Imprints Gut-Homing 
Specificity on T Cells. Immunity 2004; 21:527-38.
36. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, 
Soler D, et al. DCs metabolize sunlight-induced vitamin 
D
3
 to ‘program’ T cell attraction to the epidermal chemo-
kine CCL27. Nat Immunol 2007; 8:285-93.
37. Homey B, Wang W, Soto H, Buchanan ME, 
Wiesenborn A, Catron D, et al. Cutting Edge: The 
Orphan Chemokine Receptor G Protein-Coupled 
Receptor-2 (GPR-2, CCR10) Binds the Skin-
Associated Chemokine CCL27 (CTACK/ALP/ILC). J 
Immunol 2000; 164:3465-70.
38. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, 
Davalli AM, Adorini L. Regulatory T Cells Induced by 
1{alpha},25-Dihydroxyvitamin D
3
 and Mycophenolate 
Mofetil Treatment Mediate Transplantation Tolerance. 
J Immunol 2001; 167:1945-53.
39. Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar 
BL, Holick MF. Human prostate cells synthesize 
1,25-dihydroxyvitamin D
3
 from 25-hydroxyvitamin 
D
3
. Cancer Epidemiol Biomarkers Prev 1998; 7:391-5.
40. Reichrath J. Will analogs of 1,25-dihydroxyvitamin 
D
3
 (calcitriol) open a new era in cancer therapy? 
Onkologie 2001; 24:128-33.
41. Osborne JE, Hutchinson PE. Vitamin D and systemic 
cancer: is this relavant to malignant melanoma? Br J 
Dermatol 2002; 147:197-213.
42. Green A, Siskind V. Geographical distribution of cuta-
neous melanoma in Queensland. Med J Aust 1983; 
1:407-10.
43. Elwood JM, Gallagher RP, Hill GB, Pearson JC. 
Cutaneous melanoma in relation to intermittent and 
constant sun exposure—the western Canada Melanoma 
Study. Int J Cancer 1985; 35:427-33.
44. Westerdahl J, Olsson H, Mosback A, et al. Is the use of 
sunscreensa risk factor for melanoma? Melanoma Res 
1995; 5:59-65.
45. Vieth R. Vitamin D supplementation, 25-hydroxyvi-
tamin D concentrations, and safety. Am J Clin Nutr 
1999; 69:842-56.
46. Holick MF. Sunlight “D” ilemma: risk of skin cancer 
or bone disease and muscle weakness. Lancet 2001; 
357:961.
47. Malabanan A, Veronikis IE, Holick MF. Redefining 
vitamin D insufficiency. Lancet 1998; 351:805-6.
48. British Pediatric Association. Hypercalcemia in infants 
and vitamin D. Brit Med J 1956; 2:149.
49. Bischoff-Ferrari HA, Dawson-Huges B, Staehelin HB, 
Orav E, Stuck AE, Theiler R, et al. Fall prevention 
with supplemental and active forms of vitamin D: a 
meta-analysis of randomized controlled trials. Brit Med 
J 2009; 339:3692; doi:10.1136/bmj.b3692.
50. Bischoff-Ferrari HA, Giovannucci E, Willett WC, 
Dietrich T, Dawson-Hughes B. Estimation of optimal 
serum concentrations of 25-hydroxyvitamin D for mul-
tiple health outcomes. Am J Clin Nutr 2006; 84:18-28.
51. Armas LA, Dowell S, Akhter M, Duthuluru S, Huerter 
C, Hollis BW, et al. Ultraviolet-B radiation increases 
serum 25-hydroxyvitamin D levels: the effect of UVB 
dose and skin color. J Am Acad Dermatol 2007; 
57:588-93.
19. Holick MF. High prevalence of vitamin D inadequacy 
and implications for health. Mayo Clin Proc 2006; 
81:353-73.
20. Lehmann B, Querings K, Reichrath J. Vitamin D and 
skin: new aspects for dermatology. Exp Dermatol 2004; 
13:11-5.
21. Reichrath J, Lehmann B, Carlberg C, Varani J, et al. 
Vitamins as hormones. Horm Metab Res 2007; 39:71-84.
22. Lehmann B, Genehr T, Knuschke P, Pietzsch J, et al. 
UVB-induced conversion of 7-dehydrocholesterol to 
1α,25-dihydroxyvitamin D
3
 in an in vitro human skin 
equivalent model. J Invest Dermatol 2001; 117:1179-85.
23. Schuessler M, Astecker N, Herzig G, Vorisek G, et al. 
Skin is an autonomous organ in synthesis, two-step 
activation and degradation of vitamin D
3
: CYP27 
in epidermis completes the set of essential vitamin 
D
3
-hydroxylases. Steroids 2001; 66:399-408.
24. Vantieghem K, Kissmeyer AM, De Haes P, Bouillon R, 
et al. UVB-induced production of 1,25(OH)
2
D3 and 
vitamin D activity in human keratinocytes pretreated 
with a sterol delta 7 reductase inhibitor. J Cell Biochem 
2006; 98:81-92.
25. Lehmann B, Sauter W, Knuschke P, Dreßler S, et al. 
Demonstration of UVB-induced synthesis of 1α,25-
dihydroxyvitamin D
3
 (calcitriol) in human skin by 
microdialysis. Arch Dermatol Res 2003; 295:24-8.
26. Bär M, Domaschke D, Meye A, Lehmann B, et 
al. Wavelength-dependent induction of CYP24A1-
mRNA after UVB-triggered calcitriol synthesis in 
cultured human keratinocytes. J Invest Dermatol 2007; 
127:206-13.
27. Segaert S, Bouillon R. Epidermal keratinocytes as 
source and target cells for vitamin D. In: A Norman 
W, Bouillon R, Thomasset M, (eds): Vitamin D 
endocrine system: structural, biological, genetic and 
clinical aspects. Proceedings of the Eleventh Workshop 
on Vitamin D, Nashville TN, USA—May 27–June 
1, 2000. Printing and Reprographics University of 
California, Riverside 2000; 583-90.
28. Vantieghem K, De Haes P, Bouillon R, Segaert S. 
Dermal fibroblasts pretreated with a sterol delta7-
reductase inhibitor produce 25-hydroxyvitamin D
3
 
upon UVB irradiation. J Photochem Photobiol 2006; 
85:72-8.
29. Prystowsky JH, Muzio PJ, Sevran S, Clemens TL. 
Effect of UVB phototherapy and oral calcitriol 
(1,25-dihydroxyvitamin D
3
) on vitamin D photosyn-
thesis in patients with psoriasis. J Am Acad Dermatol 
1996; 35:690-5.
30. Guryev O, Cavalho RA, Usanov S, Gilep A, et al. A 
pathway for the metabolism of vitamin D
3
: unique 
hydroxylated metabolites formed during catalysis with 
cytochrome P450scc (CYP11A1). Proc Natl Acad Sci 
2003; 100:14754-9.
31. Albro P, Bilski P, Corbett JT, Schroeder JL, et al. 
Photochemical reactions and phototoxicity of sterols: 
novel self-perpetuating mechanism for lipid photooxy-
dation. Photochem Photobiol 1997; 66:316-25.
32. Moriuchi S, Tsuruki F, Otawara Y, Hosoya N, et al. 
Biological Activity of the endoperoxides derived from 
vitamin D derivatives by dye-sensitized photo-oxida-
tion. J Nutr Sci Vitaminol 1979; 25:455-8.
33. Johnston B, Butcher EC. Chemokines in rapid leuko-
cyte adhesion triggering and migration. Seminars in 
Immunology 2002; 14:83-92.
References
1. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, 
Hauser R, Prins GS, Soto AM. Endocrine-disrupting 
chemicals: An endocrine society scientific statement. 
Endocr Rev 2009; 30:293-342.
2. Gore AC, Heindel JJ, Zoeller T. Endocrine disruptors 
for endocrinologists (and others). Endocrinology 2006; 
147:1-3.
3. Schlumpf M, Schmid P, Durrer S, Conscience M, 
Maerkel K, Henseler M, et al. Endocrine activity and 
developmental toxicity of cosmetic UV filters—an 
update. Toxicology 2004; 205:113-22.
4. Schlumpf M, Kypke K, Vökt C, Birchler M, Durrer 
S, Faass O, et al. Endocrine active UV filters: devel-
opmental toxicity and exposure through breast milk. 
Chimia 2008; 62:345-61.
5. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The 
Danish case-control study of cutaneous malignant 
melanoma. II Importance of UV-light exposure. Int J 
Cancer 1988; 42:319-24.
6. Gorham ED, Garland FC, Garland CF. Sunlight and 
breast cancer incidence in the USSR. Int J Epidemiol 
1990; 19:614-22.
7. Garland CF, Comstock GW, Garland FC, et al. Serum 
25-hydroxyvitamin D and colon cancer: eight year 
prospective study. Lancet 1989; 1176-8.
8. Garland CF, Garland FC, Gorham ED. Can colon can-
cer incidence and death rates be reduced with calcium 
and vitamin D? Am J Clin Nutr 1991; 54:193-201.
9. Grant WB. An estimate of premature cancer mortality 
in the U.S. due to inadequate doses of solar ultraviolet-
B radiation. Cancer 2002; 94:1867-75.
10. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 
357:266-81.
11. Holick MF, Frommer JE, McNeal SC, Richtand NM, 
et al. Photometabolism of 7-dehydrocholesterol to 
previtamin D
3
 in skin. Biochem Biophys Res Commun 
1977; 76:107-15.
12. MacLaughlin JA, Anderson RR, Holick MF. Spectral 
character of sunlight modulates photosynthesis of 
previtamin D
3
 and its photoisomers in human skin. 
Science 1982; 216:1001-3.
13. Holick MF, MacLaughlin JA, Clark MB, Holick SA, et 
al. Photosynthesis of previtamin D
3
 in human skin and 
the physiologic consequences. Science 1980; 210:203-5.
14. Prosser DE, Jones G. Enzymes involved in the activa-
tion and inactivation of vitamin D. Trends Biochem Sci 
2004; 29:664-73.
15. Ohyama Y, Yamasaki T. Eight cytochrome P450S 
catalyze vitamin D metabolism. Front Biosci 2005; 
10:608-19.
16. Zehnder D, Bland R, Stewart PM, Hewison M. 
Analysis of the tissue distribution of 1α-hydroxylase 
identifies novel extra-renal sites for the synthesis of 
1,25-dihydroxyvitamin D
3
. J Endocrinol 2000; 164:1.
17. Hewison M, Burke F, Evans KN, Lammas DA, et al. 
Extrarenal 25-hydroxyvitamin D
3
-1α-hydroxylase in 
human health and disease. J Steroid Biochem Mol Biol 
2007; 103:316-21.
18. Lehmann B, Meurer M. Extrarenal sites of calcitriol 
synthesis: the particular role of the skin. In: Recent 
Results in Cancer Research; Reichrath J, Friedrich 
M, Tilgen W, (Eds.) Vitamin D Analogs in Cancer 
Prevention and Therapy, Springer Verlag 2003; 
164:135-45.
www.landesbioscience.com Dermato-Endocrinology 25
52. Osmancevic A, Landin-Wilhelmsen K, Larko O, 
Mellstrom D, Wennberg AM, Hulthen L, et al. UVB 
therapy increases 25(OH) vitamin D syntheses in 
postmenopausal women with psoriasis. Photodermatol 
Photoimmunol Photomed 2007; 23:172-8.
53. Cicarma E, Mork C, Porojnicu AC, Juzeniene A, Tam 
TT, Dahlback A, et al. Influence of narrowband UVB 
phototherapy on vitamin D and folate status. Exp 
Dermatol 2009; In press.
54. Osmancevic A, Landin-Wilhelmsen K, Larko O, 
Wennberg AM, Krogstad AL. Vitamin D produc-
tion in psoriasis patients increases less with narrow-
band than with broadband ultraviolet B photothera-
py. Photodermatol Photoimmunol Photomed 2009; 
25:119-23.
55. Rogers S, Marks J, Shuster S, Hillyard CJ. Effect of 
PUVA on serum 25-OH vitamin D in psoriatics. Br 
Med J 1979; 2:833-4.
56. Guilhou JJ, Colette C, Monpoint S, Lancrenon E, 
Guillot B, Monnier L. Vitamin D metabolism in 
psoriasis before and after phototherapy. Acta Derm 
Venereol 1990; 70:351-4.
57. Krause R, Buhring M, Hopfenmuller W, Holick MF, 
Sharma AM. Ultraviolet B and blood pressure. Lancet 
1998; 352:709-10.
58. Reddy KK, Gilchrest BA. What is all this Commotion 
about Vitamin D? J Invest Dermatol 2010; 130:321-6.
